I thought that you would find this article interesting in terms of AD pathology, and I will put it in the i-Box above.
Note also that if you check the trial links in the i-Box, they have recently been updated to show the dosage strengths, and these generally reflect the Phase II.
"....on the biotech battle-field, you need some élan...."